Clinical Trial Supply and Logistics Market - Forecasts from 2018 to 2023

March 2018 | 95 pages | ID: C92917A9024EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global clinical trial supply and logistic market was valued at US$11.437 billion in 2017 and is projected to expand at a CAGR of 8.02% over the forecast period to reach US$18.164 billion by 2023. The growing regulatory concerns regarding the conduction of a clinical trial is significantly driving the clinical trial and logistic market. Moreover, the development of new drug and medical devices are also increasing which is further supplementing the growth of the market. Simultaneously, the increasing emphasis by the manufacturers towards minimizing overage and avoiding shortages, optimizing production and packaging, and balancing shipment and supply costs are increasing the demand for efficient solutions for clinical trial supply and logistics.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the clinical trial supply and logistic value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global clinical trial supply and logistic market.

Major industry players profiled as part of the report are Sharp, DHL International GmbH, Paraxel International Corporation, and Catalent Inc. among others.

Segmentation

The global clinical trial supply and logistic market has been analyzed through following segments:

By Component

• Manufacturing
• Packaging and Labeling
• Distribution

By End Users

• Pharmaceutical
• Biologics
• Medical Device

By Geography

North America

• United States
• Canada
• Mexico
• Others

South America

• Brazil
• Argentina
• Others

Europe

• United Kingdom
• Germany
• France
• Netherlands
• Others

Middle East and Africa

• Israel
• South Africa
• Saudi Arabia
• Others

Asia Pacific

• China
• Japan
• India
• Australia
• Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC MARKET BY COMPONENT

5.1. Manufacturing
5.2. Packaging and labeling
5.3. Distribution

6. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC MARKET BY END USER

6.1. Pharmaceutical
6.2. Biologics
6.3. Medical Device

7. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC MARKET BY GEOGRAPHY

7.1. Noth America
  7.1.1. United States
  7.1.2. Canada
  7.1.3. Mexico
  7.1.4. Others
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. United Kingdom
  7.3.2. Germany
  7.3.3. France
  7.3.4. Netherlands
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. Israel
  7.4.2. South Africa
  7.4.3. Saudi Arabia
  7.4.4. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. Japan
  7.5.3. India
  7.5.4. Australia
  7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Market Share Analysis
8.2. Recent Deals and Investment
8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. DHL International GmbH
  9.1.1. Company Overview
  9.1.2. Financials
  9.1.3. Products and Services
  9.1.4. Recent Developments
9.2. Marken
  9.2.1. Company Overview
  9.2.2. Financials
  9.2.3. Products and Services
  9.2.4. Recent Developments
9.3. Parexel Internation Corporation
  9.3.1. Company Overview
  9.3.2. Financials
  9.3.3. Products and Services
  9.3.4. Recent Developments
9.4. Movianto
  9.4.1. Company Overview
  9.4.2. Financials
  9.4.3. Products and Services
  9.4.4. Recent Developments
9.5. Catalent, Inc.
  9.5.1. Company Overview
  9.5.2. Financials
  9.5.3. Products and Services
  9.5.4. Recent Developments
9.6. Patheon
  9.6.1. Company Overview
  9.6.2. Financials
  9.6.3. Products and Services
  9.6.4. Recent Developments
9.7. Almac Group
  9.7.1. Company Overview
  9.7.2. Financials
  9.7.3. Products and Services
  9.7.4. Recent Developments
9.8. FedEX
  9.8.1. Company Overview
  9.8.2. Financials
  9.8.3. Products and Services
  9.8.4. Recent Developments
9.9. PCI Pharma Services
  9.9.1. Company Overview
  9.9.2. Financials
  9.9.3. Products and Services
  9.9.4. Recent Developments
9.10. Sharp
  9.10.1. Company Overview
  9.10.2. Financials
  9.10.3. Products and Services
  9.10.4. Recent Developments